OCT 24, 2020 4:46 PM PDT

Software Flags Elevated Cerebral Palsy Risk in Premies

WRITTEN BY: Tara Fernandez

Diagnostic imaging scientists have developed a software tool for predicting the future onset of cerebral palsy in babies born prematurely. Children born earlier than 30 weeks of gestation face a staggeringly elevated risk of problems with motor development. This is in part due to abnormalities in their white matter, deep regions in the brain that contain nerve fibers. 

Almost 70 percent of babies born extremely prematurely display these white matter abnormalities and up to 10 percent of them go on to develop cerebral palsy, or CP, a permanent and incurable movement disorder. 

According to experts, earlier CP diagnoses lead to earlier interventions, transforming the quality of life for both the children affected and their caregivers. Physical therapy, for example, if initiated early in the child’s development, could help reduce symptoms of CP including stiffness, tremors, and problems with fine motor control. Current neuroimaging technologies are unfortunately not able to achieve this, largely due to sensitivity constraints and highly subjective assessment protocols.

Neonatologist Nehal Parikh from Cincinnati Children’s Hospital Medical Center led a team that developed a computational tool to analyze magnetic resonance imaging (MRI) scans taken of preterm infants, flagging those with signature anatomical defects that correlate with an increased CP risk. This biomarker is termed diffuse white matter abnormality, or DWMA, and can be picked up in MRI scans as regions with more intense signals as compared to surrounding healthy tissues. Neurologists believe that these darker regions are due to inflammation in the white matter.

“Manual tracing of DWMA regions within the brain is highly subjective and produces poor reliability and reproducibility,” said Parikh. “It is clear that we need a better tool for diagnostics. I started working with computer scientists to come up with an algorithm that can segment these lesions.”

The “training” regime for the algorithm involved the team’s computer scientists manually tracing locations of DWMA, normal white matter, gray matter, and cerebrospinal fluid. Once fed with a database of MRI scans from both preterm and normal term babies, the resulting algorithm was found to have an accuracy of over 95 percent.

The next step is integrating automation, for which the team is currently collaborating with MRI vendors to achieve. “Ideally, when the MRI scan is complete, our algorithm would do its job within seconds and provide a value for diffuse white matter abnormality,” said Parikh. “If this value was abnormal, the child would be referred for aggressive early intervention therapies and/or research trials of novel interventions.”

 

Sources: Scientific Reports, Physics World

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 06, 2020
Cardiology
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
AUG 06, 2020
Identifying a Prognostic Biomarker for Neurological Deterioration After a Stroke
Strokes are life-changing events that can cause a myriad of issues even after it is over. Plenty of tests, such as the n ...
SEP 02, 2020
Cancer
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
SEP 02, 2020
Does Adjuvant Chemotherapy Really Help in a Rare Signet-ring Cell Carcinoma
For many rare diseases, there is a lack of a “standard” treatment options. This is more prevalent in diverse ...
SEP 17, 2020
Coronavirus
A Biomarker May Predict the Most Severe COVID-19 Cases
SEP 17, 2020
A Biomarker May Predict the Most Severe COVID-19 Cases
Researchers may have found a way to identify the COVID-19 patients that will need targeted therapies the most.
SEP 21, 2020
Clinical & Molecular DX
Smart Wearable Patch Signals Trouble Following Traumatic Injury
SEP 21, 2020
Smart Wearable Patch Signals Trouble Following Traumatic Injury
An ambulance pulls up to the site of a car accident, sirens blazing. Paramedics assess the crash victims, looking for si ...
NOV 07, 2020
Neuroscience
Device Measures Stress Hormones with Earwax
NOV 07, 2020
Device Measures Stress Hormones with Earwax
Researchers from University College London and King’s College London in the UK have developed a device that can me ...
NOV 17, 2020
Clinical & Molecular DX
Tumor Stiffness Linked to Its Aggressiveness
NOV 17, 2020
Tumor Stiffness Linked to Its Aggressiveness
  As tumors grow, tiny areas at their cores are found to become stiff prior to metastasis, or the spread of cancer ...
Loading Comments...